UNSPSC 85322702: Diagnosis of hypersplenism

This classification denotes the group of activities that yields a diagnosis of Hypersplenism. Hypersplenism is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code D73. 1

UNSPSC 85322702 Diagnosis of hypersplenism (Commodity) bears little relationship to the state and local procurement activity currently tagged under it. The code nominally addresses medical diagnosis of an enlarged spleen, yet the three recent opportunities posted under this code solicit diagnostic imaging systems (a PACS platform), ultrasound equipment (the KOSMOS platform with probes and accessories), and phlebotomy services for blood collection — none of which align with hypersplenism diagnosis specifically. This mismatch suggests a tagging error in the underlying procurement systems rather than legitimate market activity under the code's intended scope. State and local governments do procure clinical diagnostic services and medical equipment, but the opportunities here span imaging infrastructure, point-of-care ultrasound, and specimen collection rather than spleen-specific pathology assessment.

The three opportunities span different issuing bodies and geographies: San Mateo County Medical Center (California) posted an RFP for Diagnostic Imaging PACS implementation due August 7, 2026, with a five-year contract term and local preference of 5–10% available; Collier County, Florida, issued a Notice of Intent to Single Source EchoNous, Inc., for ultrasound equipment and a five-year warranty with a contract period of March 26, 2026, to March 25, 2028; and the Albuquerque Police Department (New Mexico) issued an RFB for on-call phlebotomy services due February 25, 2026, with an initial three-year term renewable for up to two additional one-year periods. The code shows activity in California, Florida, and New Mexico but lacks sufficient alignment with its stated commodity scope to support reliable forward forecasting or business development strategy.